Analystreport

Opiant Pharmaceuticals Inc (NASDAQ: OPNT) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.

Opiant Pharmaceuticals, Inc.  (OPNT) 
Last opiant pharmaceuticals, inc. earnings: 3/4 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.opiant.com/investor-overview